Boundless Intelligence, Empowered AI: Digital Innovation Salon on AI-Driven Pharmaceutical Marketing Concludes Successfully in Shanghai
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
Sanofi
Pharmaceutical Manufacturer
Recently, the "Pharmaceutical Marketing Digital and Intelligent Innovation Salon," co-hosted by Masterland and Taimei Medical Technology, successfully concluded in Shanghai. Centered on the core theme "Boundless Digital Intelligence, AI in Action," the event gathered marketing executives and training directors from several leading pharmaceutical companies to share insights and exchange views on trending topics such as the compliance storm in pharmaceutical marketing and the practical effectiveness of AI agent implementations.
Guest Sharing:
How AI Drives Marketing Transformation Amid the Compliance Storm?
Long Xuyang, Head of the AI Promotion Division for the Out-of-Hospital Market at Qilu Pharmaceutical, shared practical experiences in promoting and implementing AI agents within pharmaceutical enterprises. Lin Hua, Training Director at Hutchison MediPharma, delivered a presentation titled 《Embracing AI Transformation, Empowering Full-Scenario Pharmaceutical Sales》, sharing the implementation practices and outcomes of AI training companions across the entire pharmaceutical sales process, clearly demonstrating the core value of digital-intelligent empowerment. Zhao Liangshen, Head of the Type 1 Diabetes Business Unit at Sanofi, shared data-driven market insights, highlighting the substantial advancements of "real-time intelligence" over traditional "experience-based decision-making."
Huang Yufei, Head of Digital & Intelligent Marketing Products at Taimei, delivered a presentation titled “AI-Driven Leap in Sales Capabilities and Marketing Transformation”.
AI Breakthrough:
Boundless Platform: Full-Scenario Empowerment
One-Stop Solution for Building a High-Standard Compliance Marketing System
Amid the continuously tightening regulatory landscape for pharmaceutical compliance, the core of marketing management for pharmaceutical companies is no longer merely about completing approval workflows. Instead, it requires demonstrating within academic promotion scenarios—such as medical representative registration, hospital visits, conference activities, promotional material usage, and new drug development—that there is "compliant personnel, compliant conduct, authentic processes, and complete evidence."
The Taimei Wujie Platform integrates AI compliance capabilities into business systems such as CRM, Event, AI simulation training, and the Content Center, bridging key scenarios including representative visits, meetings, content, and training to achieve unified management of rule synchronization, risk identification, and evidence retention:
Front-end access control is enforced by integrating with CRM, HR, AI training simulators, and external national filing management platforms, with AI intelligently assisting in completing representative qualification reviews, product and compliance knowledge training certifications, filing status verifications, and medical institution registration management, ensuring that representatives may only conduct academic promotion after meeting all access requirements;
Process-controlled behavior, the AI assistant identifies risky expressions in real time, such as sensitive phrasing, absolute claims, and exaggerated efficacy, and provides compliance revision suggestions; meanwhile, it integrates with Event management to conduct rule validation and evidence archiving across stages including meeting initiation, speaker invitation, attendee check-in, and post-event filing, thereby strengthening behavioral compliance and event authenticity management;
The backend ensures strict evidence control. Throughout the management and audit processes, it leverages AI compliance alerts, risk stratification, corrective action tracking, and evidence archiving to establish a closed-loop compliance management system that is searchable, verifiable, and traceable, thereby supporting verification, internal audits, and regulatory inspections.
Through "Process Control + AI Recognition + Risk Early Warning + Audit Trail", the Taimei Wujie Platform enables pharmaceutical companies to establish an actionable, monitorable, and auditable marketing compliance management system, facilitating the transition of medical representatives toward a professional and academically driven promotion model.
Roundtable:
How to Solve the "Last Mile" Challenge in AI Implementation?
The roundtable session was moderated by Zhao Geng, Head of Digital & Intelligent Marketing Business at Taimei. Themed "Bridging the Last Mile of AI Implementation," the panelists included Lin Hua, Zhao Liangshen, Huang Yufei, and Shen Ming, Director of Digital Marketing and Patient Management Products at Novartis Pharmaceuticals.
The guest noted that AI agents hold immense application potential in the pharmaceutical marketing sector, especiallyIn the current context of increasingly stringent compliance requirements and intensifying competition in academic marketing, pharmaceutical companies must proactively embrace AI to address internal challenges such as data silos, data quality, and compliance framework development. They should fully recognize and experience both the advanced capabilities and limitations of AI agents, avoid pitfalls such as "superficial empowerment" and "replacement anxiety," and genuinely apply AI technologies to frontline operations to unlock their full technical value.
Taking a leading pharmaceutical company in China as an example, Taimei's AI role-play training has been comprehensively implemented across scenarios such as new employee onboarding, pre-launch training, and pre-POA meeting preparation. AI role-play modules, including Q&A simulations, customer visit drills, and departmental meeting simulations, have been deployed to the sales team, achieving a user satisfaction score of 9.1 (out of 10). Users widely acknowledge the high realism of the AI simulation scenarios, which significantly shorten the onboarding period for new sales representatives and effectively boost their confidence in customer visits.
Conference Highlights
Conclusion:
Understanding and embracing AI are the fundamental principles for survival in the AI era. As a leading AI-powered clinical development platform for pharmaceuticals, Taimei will continue to advance the innovative application of AI technologies in pharmaceutical marketing. Centered on "AI for Success", it will empower pharmaceutical enterprises to overcome growth challenges, build digital-intelligent core competitiveness, and collaboratively usher in a new era of intelligent pharmaceutical marketing.
